Open access · OA
via OpenAlex
Targeting Aging Mechanisms: Pharmacokinetic And Admet Challenges In Senescent Physiology
Sonali K. Diwate, Suresh G. Killedar, Deepak Sawant, Rushikesh Kumbhar, Vaishnavi Hiremath, Vaishnavi Koulge, Anuja More, ABHINANDAN RAVSAHEB PATIL
International Journal of Drug Delivery Technology · 2026
Dysbiosis
Mitochondrial dysfunction
Cellular senescence
Senolytics
Rapamycin / mTOR inhibition
Human
Preclinical / animal
Review
Abstract
Natural bioactive agents include flavonoids, mitochondrial-targeted antioxidants, and NAD+ precursors are under growing investigation as well as synthetic agents like dasatinib and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) as promising senotherapeutics due to their ability to control these hallmarks. This broad overview incorporates the mechanistic understanding of the action of both plant-derived and synthetic agents on major aging processes and, in particular, the pharmacodynamics and pharmacokinetics of their actions in aging (or senescence(definition)) physiology. The changes in the performance of the CYP450 enzymes, tissue distributions, renal and hepatic clearance as well as gut microbiome composition with age significantly alter the ADMET profile of these agents, which affects the efficacy and safety of these agents. We critically review translational barriers, uncover gaps in age-relevant preclinical models, and suggest strategic solutions on how best to streamline senotherapeutic dosing and delivery system. Through a synthesis of the views of pharmacognosy, molecular geroscience, and translational pharmacology, this synthesis offers a holistic approach to safe and effective interventions that can lengthen healthspan(definition) in aging people.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.25258/ijddt.16.15s.46
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Diwate, S.K., Killedar, S.G., Sawant, D., Kumbhar, R., Hiremath, V., Koulge, V., More, A., & PATIL, A.R. (2026). Targeting Aging Mechanisms: Pharmacokinetic And Admet Challenges In Senescent Physiology. <em>International Journal of Drug Delivery Technology</em>. https://doi.org/10.25258/ijddt.16.15s.46
Vancouver
Diwate SK, Killedar SG, Sawant D, Kumbhar R, Hiremath V, Koulge V, et al. Targeting Aging Mechanisms: Pharmacokinetic And Admet Challenges In Senescent Physiology. International Journal of Drug Delivery Technology. 2026. doi:10.25258/ijddt.16.15s.46.
BibTeX
@article{sonali2026Target,
title = {Targeting Aging Mechanisms: Pharmacokinetic And Admet Challenges In Senescent Physiology},
author = {Sonali K. Diwate and Suresh G. Killedar and Deepak Sawant and Rushikesh Kumbhar and Vaishnavi Hiremath and Vaishnavi Koulge and Anuja More and ABHINANDAN RAVSAHEB PATIL},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
doi = {10.25258/ijddt.16.15s.46},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biology Direct 2016
Open access · CC-BY
The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease
Current Opinion in Nephrology & Hypertension 2011
Citation only
Aging and the kidney
Kidney International Supplements 2014
Open access · OA
Fibrosis and renal aging
Cell stress 2026
Open access · OA
MicroRNA as key players in skin regeneration and anti-aging pathways.
Translational and Clinical Medicine - Georgian Medical Journal 2025
Open access · OA
Advances in Rejuvenation Research: Molecular Mechanisms and Emerging Therapeutic Strategies
International Journal of Molecular Sciences 2023
Open access · CC-BY